GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

Rating:
Outperform
AEGR
down 81.39 %

Aegerion Pharmaceuticals, Inc. (AEGR) rated Outperform with price target $111 by FBR Capital

Posted on: Thursday,  Oct 31, 2013  8:25 AM ET by FBR Capital

FBR Capital rated Outperform Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on 10/31/2013. Previously FBR Capital rated Outperform Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on
10/30/2013., when the stock price was $95.45. Since then, Aegerion Pharmaceuticals, Inc. has lost 81.39% as of 01/27/2016's recent price of $17.76.
If you would have followed the previous FBR Capital's recommendation on AEGR, you would have lost 81.39% of your investment in 819 days.

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.

FBR Capital uses a highly disciplined analysis focused on intrinsic value, which we developed to critically examine the capital structure of the companies we cover, as well as their competitive positions and the growth opportunities within their industries. We apply this discipline – which helps us assess how effectively a company’s managers deploy the capital entrusted to them – not only in our published research but also when making investing and underwriting judgments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2013 8:25 AM Buy
None
86.49 111.00
as of 12/13/2013
1 Week down  -1.19 %
1 Month down  -19.47 %
3 Months down  -23.45 %
1 YTD down  -23.45 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2013 8:25 AM Buy
None
95.45 105.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy